1. Home
  2. BHVN vs ARCB Comparison

BHVN vs ARCB Comparison

Compare BHVN & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • ARCB
  • Stock Information
  • Founded
  • BHVN 2013
  • ARCB 1923
  • Country
  • BHVN United States
  • ARCB United States
  • Employees
  • BHVN N/A
  • ARCB N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • ARCB Trucking Freight/Courier Services
  • Sector
  • BHVN Health Care
  • ARCB Industrials
  • Exchange
  • BHVN Nasdaq
  • ARCB Nasdaq
  • Market Cap
  • BHVN 1.9B
  • ARCB 1.6B
  • IPO Year
  • BHVN 2017
  • ARCB N/A
  • Fundamental
  • Price
  • BHVN $14.63
  • ARCB $83.03
  • Analyst Decision
  • BHVN Strong Buy
  • ARCB Buy
  • Analyst Count
  • BHVN 14
  • ARCB 13
  • Target Price
  • BHVN $58.85
  • ARCB $92.92
  • AVG Volume (30 Days)
  • BHVN 2.0M
  • ARCB 411.1K
  • Earning Date
  • BHVN 08-07-2025
  • ARCB 07-30-2025
  • Dividend Yield
  • BHVN N/A
  • ARCB 0.58%
  • EPS Growth
  • BHVN N/A
  • ARCB 50.16
  • EPS
  • BHVN N/A
  • ARCB 7.55
  • Revenue
  • BHVN N/A
  • ARCB $4,109,676,999.00
  • Revenue This Year
  • BHVN $3.00
  • ARCB $0.24
  • Revenue Next Year
  • BHVN $59.97
  • ARCB $6.18
  • P/E Ratio
  • BHVN N/A
  • ARCB $11.00
  • Revenue Growth
  • BHVN N/A
  • ARCB N/A
  • 52 Week Low
  • BHVN $13.87
  • ARCB $55.19
  • 52 Week High
  • BHVN $55.70
  • ARCB $129.83
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.97
  • ARCB 78.29
  • Support Level
  • BHVN $14.00
  • ARCB $67.83
  • Resistance Level
  • BHVN $15.09
  • ARCB $84.91
  • Average True Range (ATR)
  • BHVN 0.73
  • ARCB 2.82
  • MACD
  • BHVN 0.13
  • ARCB 1.41
  • Stochastic Oscillator
  • BHVN 41.44
  • ARCB 94.14

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: